New Delhi announced on Thursday that India had provided COVID-19 vaccines to Cambodia and Thailand as part of a Quad project, though not the Johnson & Johnson shot as intended.
When the leaders of India, the United States, Japan, and Australia meet in Japan on Tuesday, they may address the vaccine supply plan, as per the Indian foreign ministry spokesman Arindam Bagchi.
“Vaccines have been provided to Cambodia and Thailand under the Quad umbrella,” Mr Bagchi stated.
Mr Bagchi did not provide figures, but according to data from the Indian foreign ministry, India shipped 200,000 doses of Covovax, a variant of the Novavax vaccine manufactured by the Serum Institute of India (SII), to Thailand under the Quad programme last month.
According to the statistics, India exported 325,000 doses of Covishield, a variant of the AstraZeneca injection manufactured by the SII, to Cambodia.
As a reaction to China’s vaccine gifts around the world, the Quad was scheduled to supply J&J doses created by Indian company Biological E Ltd to Southeast Asian and other countries.
A request for comment from Biological E was not immediately returned. J&J could not be reached immediately by Reuters.